Cite
HARVARD Citation
Matsubayashi, Y. et al. (2021). Association of estimated plasma volume and weight loss after long‐term administration and subsequent discontinuation of the sodium‐glucose cotransporter‐2 inhibitor tofogliflozin. Diabetes, obesity & metabolism. 23 (7), pp. 1660-1665. [Online].